SPY424.31+0.70 0.17%
DIA345.12+0.14 0.04%
IXIC14,069.42+49.09 0.35%

BRIEF-Pfizer Opposes Trips Intellectual Property Waiver For Covid-19 Vaccines

05/07/2021 14:46
BRIEF-Pfizer Opposes Trips Intellectual Property Waiver For Covid-19 Vaccines

- Pfizer Inc PFE.N:

  • PFIZER OPPOSES TRIPS INTELLECTUAL PROPERTY WAIVER FOR COVID-19 VACCINES

  • PFIZER INC - UNTIL TODAY, WE HAVE SHIPPED APPROXIMATELY 450 MILLION DOSES OF COVID-19 VACCINE

  • PFIZER INC SAYS PROPOSED WAIVER FOR COVID-19 VACCINES, THREATENS TO DISRUPT THE FLOW OF RAW MATERIALS

  • PFIZER - UPON FINALIZATION OF ALL SUPPLY AGREEMENTS, EXPECT THAT 40% OF THEM, OR MORE THAN 1 BILLION VACCINE DOSES, TO GO TO MIDDLE & LOW INCOME COUNTRIES IN 2021

  • PFIZER - CONCLUDED AGREEMENTS TO SUPPLY 116 COUNTRIES, CURRENTLY IN ADVANCED NEGOTIATIONS WITH MANY MORE FOR TOTAL OF ABOUT 2.7 BILLION VACCINE DOSES IN 2021

  • PFIZER INC SAYS CO'S INTERNAL TARGET IS TO PROVIDE 3 BILLION DOSES OF COVID-19 VACCINE IN 2021

  • PFIZER INC - CURRENTLY, RESTRICTION IS THE SCARCITY OF HIGHLY SPECIALIZED RAW MATERIALS NEEDED TO PRODUCE OUR VACCINE

  • PFIZER CEO SAYS WTO'S PROPOSED WAIVER IS GOING TO "CREATE MORE PROBLEMS"

Source text: (https://bit.ly/3nX2X4S)

Further company coverage: PFE.N


(([email protected];))